HilleVax

Website for Vaccine Startup

Whattaya know…another biopharma startup.

Well, not exactly. HilleVax is a vaccine startup that already has a drug in Phase II.

Now that’s coming out of stealth mode in a hurry.

Nothing to prove

The struggle a lot of biopharmas have when they’re in stealth mode is they don’t have any data, so it’s always a trick to ‘tell the story.’

But when you have positive data from your Phase I trials and you’re announce a new contract with Takeda, it’s simply a matter of presenting your company with gravitas.

HilleVax’s new site raises awareness of norovirus and its burden on society with simple, straight-foward facts.

Here’s to a successful Phase II, guys.